Nishida K, Amagishi H, Sasaki H, Nakamura J
School of Pharmaceutical Sciences, Nagasaki University, Japan.
J Pharm Pharmacol. 1995 Dec;47(12A):1032-5. doi: 10.1111/j.2042-7158.1995.tb03292.x.
The importance of the injection site on the pharmacokinetics of phenol red and bromphenol blue as model drugs after intraperitoneal administration into rat was examined. Their absorption rate from the peritoneal cavity was faster after intraperitoneal administration to the liver surface than that after intraperitoneal administration to the distal small intestine, as shown by the increase in maximum concentration and decrease in mean residence time in plasma. A similar tendency was observed in the biliary excretion pattern. The enhanced absorption rate was supported by the significantly smaller amount of both drugs remaining in the peritoneal cavity at 15 min after liver surface administration than that after small intestine administration. The liver concentration of the model drugs at 15 min after liver surface administration was 1.5-2.0 times that after small intestine administration. Accordingly, liver surface administration was shown to be effective with good absorption and efficient drug delivery to the liver.
研究了腹腔注射部位对大鼠腹腔注射酚红和溴酚蓝这两种模型药物药代动力学的影响。腹腔注射到肝脏表面后,它们从腹腔的吸收速率比腹腔注射到远端小肠后更快,这表现为血浆中最大浓度增加和平均驻留时间缩短。在胆汁排泄模式中也观察到类似趋势。肝脏表面给药后15分钟时,腹腔内残留的两种药物量均显著少于小肠给药后,这支持了吸收速率的提高。肝脏表面给药后15分钟时,模型药物的肝脏浓度是小肠给药后的1.5至2.0倍。因此,肝脏表面给药显示出具有良好的吸收效果,并能有效地将药物输送到肝脏。